1-3 of 3
Ernesto Ayala
Close
Sort by
Journal Articles

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

Clinical Trials & Observations
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, Jongphil Kim, Brian Christopher Betts, Farhad Khimani, Taiga Nishihori, Nelli Bejanyan, Hien Liu, Mohamed A. Kharfan-Dabaja, Frederick L. Locke, Rebecca Gonzalez, Michael D. Jain, Marco L. Davila, Lia Elena Perez, Asmita Mishra, Ariel Perez Perez, Karlie Balke, Ernesto Ayala, Leonel Ochoa, Omar Castaneda Puglianini, Rawan Faramand, Melissa Alsina, Hany Elmariah, Michael L. Nieder, Hugo Fernandez, Claudio Anasetti, Joseph A. Pidala
Journal: Blood Advances
Blood Adv (2022) 6 (1): 259–269.
https://doi.org/10.1182/bloodadvances.2021005552
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention

Clinical Trials & Observations
Lia Perez, Hugo Fernandez, Mohamed Kharfan-Dabaja, Farhad Khimani, Brian Betts, Asmita Mishra, Ernesto Ayala, Frederick L. Locke, Leonel Ochoa-Bayona, Michael Nieder, Joseph Pidala, Alex Achille, John Powers, Eva Sahakian, Ram Thapa, Xuefeng Wang, Claudio Anasetti
Journal: Blood Advances
Blood Adv (2021) 5 (13): 2740–2750.
https://doi.org/10.1182/bloodadvances.2021004225
Published: 2021
Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Clinical Trials & Observations
Nelli Bejanyan, Joseph A. Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori, Hany Elmariah, Aleksandr Lazaryan, Farhad Khimani, Marco L. Davila, Asmita Mishra, Rawan Faramand, Michael D. Jain, Leonel Ochoa, Lia Elena Perez, Hien Liu, Melissa Alsina, Mohamed A. Kharfan-Dabaja, Hugo Fernandez, Michael L. Nieder, Frederick L. Locke, Claudio Anasetti, Ernesto Ayala
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1154–1163.
https://doi.org/10.1182/bloodadvances.2020003779
Published: 2021